Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cotterill

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Medical and Pediatric Oncology|July 24, 2001
Neuroblastoma: changing incidence and survival in young people aged 0-24 years. A report from the North of England Young Persons' Malignant Disease RegistryS J Cotterill, L Parker, L More, et al.
The Journal of Organic Chemistry|June 10, 2010
Thermal 1,3-trityl migrations in Diels-Alder domino reactions of 1-trityl-4-vinyl-1H-imidazolesLynsey J Cotterill, Ross W Harrington, William Clegg, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1997
Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working PartyA W Craft, S J Cotterill, J A Bullimore, et al.
Pediatric Blood & Cancer|January 31, 2004
Stature of young people with malignant bone tumorsSimon J Cotterill, Charlotte M Wright, Mark S Pearce, et al.
Melanoma Research|July 29, 2003
Skin cancer in children and young adults: 28 years' experience from the Northern Region Young Person's Malignant Disease Registry, UKMark S Pearce, Louise Parker, Simon J Cotterill, et al.
Pediatric Blood & Cancer|August 9, 2005
Cancer in adolescents and young adults aged 15-24 years: a report from the North of England young person's malignant disease registry, UKMark S Pearce, Louise Parker, Kevin P Windebank, et al.
Medical and Pediatric Oncology|July 24, 2001
Late relapse and prognosis for neuroblastoma patients surviving 5 years or more: a report from the European Neuroblastoma Study Group "Survey"S J Cotterill, A D Pearson, J Pritchard, et al.
British Journal of Cancer|August 6, 2000
Incidence and survival for cancer in children and young adults in the North of England, 1968-1995: a report from the Northern Region Young Persons' Malignant Disease RegistryS J Cotterill, L Parker, A J Malcolm, et al.
Phytopathology|October 24, 2008
Spatiotemporal analysis of epiphytotics of downy mildew of oilseed poppy in tasmania, australiaJ B Scott, F S Hay, C R Wilson, et al.
Pediatric Blood & Cancer|November 17, 2004
High dose melphalan in the treatment of advanced neuroblastoma: results of a randomised trial (ENSG-1) by the European Neuroblastoma Study GroupJon Pritchard, Simon J Cotterill, Shirley M Germond, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Medical and Pediatric Oncology|July 24, 2001
Neuroblastoma: changing incidence and survival in young people aged 0-24 years. A report from the North of England Young Persons' Malignant Disease RegistryS J Cotterill, L Parker, L More, et al.
The Journal of Organic Chemistry|June 10, 2010
Thermal 1,3-trityl migrations in Diels-Alder domino reactions of 1-trityl-4-vinyl-1H-imidazolesLynsey J Cotterill, Ross W Harrington, William Clegg, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1997
Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working PartyA W Craft, S J Cotterill, J A Bullimore, et al.
Pediatric Blood & Cancer|January 31, 2004
Stature of young people with malignant bone tumorsSimon J Cotterill, Charlotte M Wright, Mark S Pearce, et al.
Melanoma Research|July 29, 2003
Skin cancer in children and young adults: 28 years' experience from the Northern Region Young Person's Malignant Disease Registry, UKMark S Pearce, Louise Parker, Simon J Cotterill, et al.
Pediatric Blood & Cancer|August 9, 2005
Cancer in adolescents and young adults aged 15-24 years: a report from the North of England young person's malignant disease registry, UKMark S Pearce, Louise Parker, Kevin P Windebank, et al.
Medical and Pediatric Oncology|July 24, 2001
Late relapse and prognosis for neuroblastoma patients surviving 5 years or more: a report from the European Neuroblastoma Study Group "Survey"S J Cotterill, A D Pearson, J Pritchard, et al.
British Journal of Cancer|August 6, 2000
Incidence and survival for cancer in children and young adults in the North of England, 1968-1995: a report from the Northern Region Young Persons' Malignant Disease RegistryS J Cotterill, L Parker, A J Malcolm, et al.
Phytopathology|October 24, 2008
Spatiotemporal analysis of epiphytotics of downy mildew of oilseed poppy in tasmania, australiaJ B Scott, F S Hay, C R Wilson, et al.
Pediatric Blood & Cancer|November 17, 2004
High dose melphalan in the treatment of advanced neuroblastoma: results of a randomised trial (ENSG-1) by the European Neuroblastoma Study GroupJon Pritchard, Simon J Cotterill, Shirley M Germond, et al.
Pageof 3